THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS
Elneily, D., Tahoun, M., Elsayed, F., Abdullahi, N. (2025). THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS. EKB Journal Management System, 7(1), 57-58. doi: 10.21608/alexpo.2025.367923.2115
Dalia Abd El Moaty Elneily; Mona Moustafa Tahoun; Fatma Elsayed; Naima Abdullahi. "THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS". EKB Journal Management System, 7, 1, 2025, 57-58. doi: 10.21608/alexpo.2025.367923.2115
Elneily, D., Tahoun, M., Elsayed, F., Abdullahi, N. (2025). 'THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS', EKB Journal Management System, 7(1), pp. 57-58. doi: 10.21608/alexpo.2025.367923.2115
Elneily, D., Tahoun, M., Elsayed, F., Abdullahi, N. THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS. EKB Journal Management System, 2025; 7(1): 57-58. doi: 10.21608/alexpo.2025.367923.2115

THE CLINICOPATHOLOGIC SIGNIFICANCE OF MATRIX METALLOPROTEINASE 1 GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA PATIENTS

ALEXMED ePosters
Article 1, Volume 7, Issue 1, January 2025, Page 57-58  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2025.367923.2115
View on SCiNiTO View on SCiNiTO
Authors
Dalia Abd El Moaty Elneily1; Mona Moustafa Tahoun2; Fatma Elsayed3; Naima Abdullahi email 4
1Department of Clinical and Chemical Pathology Faculty of Medicine, University of Alexandria
2Department of Clinical and Chemical Pathology, Faculty of Medicine University of Alexandria.
3Alexandria university hospital, clinical hematology, Alexandria, Egypt
4Alexandria university hospital, clinical and chemical pathology, Alexandria, Egypt
Abstract
The bone marrow (BM) microenvironment of acute myeloid leukemia patients is extensively altered, contributing to the severity of the disease as well as causing an antitumor immune surveillance. Matrix metalloproteinase 1 (MMP-1) is a secreted protein of collagenase groups in the bone marrow microenvironment that functions to remodel the extracellular matrix. Studies have demonstrated the role of MMP-1 as diagnostic and prognostic biomarker in esophageal, bladder and other solid tumors. Its value in hematological malignancies is yet to be elucidated.

Aims
We sought to assess the differences in MMP-1 gene expression between AML patients compared to controls and its correlation with the patient’s clinical and laboratory characteristics.
Methods
MMP-1 gene expression from bone marrow aspirates of 60 newly diagnosed de novo AML cases and 40 controls with benign hematological conditions was assessed by real time polymerase chain reaction (PCR) method and the results of the relative gene expression statistically correlated with hematology, clinical chemistry results as well as flow cytometry and cytogenetic findings of the cases. A p value ≤ 0.05 was statistically significant.
Keywords
ACUTE MYELOID LEUKEMIA; GENE EXPRESSION; MATRIX METALLOPROTEINASE
Supplementary Files
Statistics
Article View: 24